Journal details
CANCER IMMUNOLOGY RESEARCH
AMER ASSOC CANCER RESEARCH · ISSN 2326-6066 · eISSN 2326-6074
SCIEScopusMEDLINEPubMedPMC
Overview
CANCER IMMUNOLOGY RESEARCH. ISSN 2326-6066 · eISSN 2326-6074. published by AMER ASSOC CANCER RESEARCH. United States. Oncology · Immunology. impact factor 7.9 (2025). JCR Q1. CAS Zone 1 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 300 articles · 2025: 451 articles · 2024: 271 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of CANCER IMMUNOLOGY RESEARCH?
The impact factor recorded for CANCER IMMUNOLOGY RESEARCH is 7.9 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of CANCER IMMUNOLOGY RESEARCH?
CANCER IMMUNOLOGY RESEARCH is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index CANCER IMMUNOLOGY RESEARCH?
CANCER IMMUNOLOGY RESEARCH is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.